1. Combinatorial therapy in tumor microenvironment: Where do we stand?
   Smita Kumari et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
2. SULF1 Activates the VEGFR2/PI3K/AKT Pathway to Promote the Development of Cervical Cancer
   Juan Li et al, 2024, Current Cancer Drug Targets CrossRef
3. MCPIP1-mediated NFIC alternative splicing inhibits proliferation of triple-negative breast cancer via cyclin D1-Rb-E2F1 axis
   Fengxia Chen et al, 2021, Cell Death & Disease CrossRef
4. Extracellular Heparan 6-O-Endosulfatases SULF1 and SULF2 in Head and Neck Squamous Cell Carcinoma and Other Malignancies
   Yang Yang et al, 2022, Cancers CrossRef
5. Global proteomic analysis of insulin receptor interactors in glomerular podocytes
   Salman B. Hosawi et al, 2020, Wellcome Open Research CrossRef
6. Clinical considerations of CDK4/6 inhibitors in triple-negative breast cancer
   Runtian Wang et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
7. 6-O-endosulfatases in tumor metastasis: heparan sulfate proteoglycans modification and potential therapeutic targets
   Mengzhen Han, 2024, American Journal of Cancer Research CrossRef
8. Methylation Mediated Silencing of miR-155 Suppresses the Development of Preeclampsia In Vitro and In Vivo by Targeting FOXO3
   Xiaohua Luo et al, 2022, Mediators of Inflammation CrossRef